Pramod Darvin

3.1k total citations · 1 hit paper
27 papers, 2.3k citations indexed

About

Pramod Darvin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pramod Darvin has authored 27 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Pramod Darvin's work include Cytokine Signaling Pathways and Interactions (10 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Bone Metabolism and Diseases (4 papers). Pramod Darvin is often cited by papers focused on Cytokine Signaling Pathways and Interactions (10 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Bone Metabolism and Diseases (4 papers). Pramod Darvin collaborates with scholars based in South Korea, India and United Kingdom. Pramod Darvin's co-authors include Eyad Elkord, Varun Sasidharan Nair, Salman M. Toor, Young Mok Yang, Youn Hee Joung, Nipin Sp, Dong Young Kang, Hyo Joo Byun, Hak‐Kyo Lee and Kyung Do Park and has published in prestigious journals such as PLoS ONE, Nutrients and Journal of Cellular Biochemistry.

In The Last Decade

Pramod Darvin

27 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune checkpoint inhibitors: recent progress and potential biomarkers

2018 1.5k citations Pramod Darvin, Salman M. Toor et al. Experimental & Molecular Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pramod Darvin South Korea	16	1.2k	832	692	407	343	27	2.3k
Dang Wu China	28	1.1k 0.9×	934 1.1×	802 1.2×	333 0.8×	564 1.6×	56	2.5k
An Wouters Belgium	27	965 0.8×	1.1k 1.3×	355 0.5×	388 1.0×	497 1.4×	73	2.2k
Yi‐Jun Wang United States	29	1.6k 1.4×	982 1.2×	646 0.9×	203 0.5×	215 0.6×	75	2.5k
Yao Yao China	25	1.1k 0.9×	825 1.0×	731 1.1×	182 0.4×	227 0.7×	83	2.2k
Elisabeth Letellier Luxembourg	26	895 0.8×	1.3k 1.5×	444 0.6×	253 0.6×	726 2.1×	42	2.4k
Carmine Carbone Italy	29	911 0.8×	1.2k 1.4×	354 0.5×	385 0.9×	537 1.6×	84	2.3k
Radosław Zagożdżon Poland	25	803 0.7×	792 1.0×	820 1.2×	184 0.5×	213 0.6×	104	2.2k
Uddalak Bharadwaj United States	26	1.1k 0.9×	1.1k 1.3×	691 1.0×	335 0.8×	486 1.4×	57	2.9k
Johannes Lemke Germany	21	658 0.6×	1.1k 1.3×	419 0.6×	255 0.6×	284 0.8×	43	1.8k
Xiyun Deng China	32	1.2k 1.0×	1.6k 1.9×	736 1.1×	378 0.9×	903 2.6×	95	3.4k

Countries citing papers authored by Pramod Darvin

Since Specialization

Citations

This map shows the geographic impact of Pramod Darvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pramod Darvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pramod Darvin more than expected).

Fields of papers citing papers by Pramod Darvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pramod Darvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pramod Darvin. The network helps show where Pramod Darvin may publish in the future.

Co-authorship network of co-authors of Pramod Darvin

This figure shows the co-authorship network connecting the top 25 collaborators of Pramod Darvin. A scholar is included among the top collaborators of Pramod Darvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pramod Darvin. Pramod Darvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Darvin, Pramod, K. M. Jagathnath Krishna, Paul Augustine, et al.. (2023). Co-expression of galectin-3 and vimentin in triple negative breast cancer cells promotes tumor progression, metastasis and survival. Tumor Biology. 45(1). 31–54. 7 indexed citations

Shine, V. J., et al.. (2023). A high-throughput screening system for SARS-CoV-2 entry inhibition, syncytia formation and cell toxicity. Biological Procedures Online. 25(1). 22–22. 4 indexed citations

Darvin, Pramod, Easwaran Sreekumar, Shijulal Nelson‐Sathi, et al.. (2022). A rapid bead-based assay for screening of SARS-CoV-2 neutralizing antibodies. PubMed. 5(2). 100–110. 3 indexed citations

Darvin, Pramod, et al.. (2020). Mitochondria targeted redox GFP reveals time and dose dependent onset and progression of mitochondrial oxidation with diverging cell death decisions during photodynamic therapy. Photodiagnosis and Photodynamic Therapy. 31. 101921–101921. 2 indexed citations

Darvin, Pramod, Varun Sasidharan Nair, & Eyad Elkord. (2019). PD-L1 Expression in Human Breast Cancer Stem Cells Is Epigenetically Regulated through Posttranslational Histone Modifications. Journal of Oncology. 2019. 1–9. 59 indexed citations

Darvin, Pramod, et al.. (2018). A high-throughput real-time in vitro assay using mitochondrial targeted roGFP for screening of drugs targeting mitochondria. Redox Biology. 20. 379–389. 27 indexed citations

Darvin, Pramod, Salman M. Toor, Varun Sasidharan Nair, & Eyad Elkord. (2018). Immune checkpoint inhibitors: recent progress and potential biomarkers. Experimental & Molecular Medicine. 50(12). 1–11. 1503 indexed citations breakdown →

Byun, Hyo Joo, Pramod Darvin, Dong Young Kang, et al.. (2017). Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells. Oncology Reports. 37(6). 3270–3278. 57 indexed citations

Sp, Nipin, Dong Young Kang, Youn Hee Joung, et al.. (2017). Methylsulfonylmethane Induces G1 Arrest and Mitochondrial Apoptosis in YD-38 Gingival Cancer Cells. Anticancer Research. 37(4). 1637–1646. 17 indexed citations

10.

Joung, Youn Hee, Pramod Darvin, Dong Young Kang, et al.. (2016). Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities. PLoS ONE. 11(7). e0159891–e0159891. 37 indexed citations

11.

Joung, Youn Hee, Pramod Darvin, Dong Young Kang, et al.. (2016). Methylsulfonylmethane enhances BMP-2-induced osteoblast differentiation in mesenchymal stem cells. Molecular Medicine Reports. 14(1). 460–466. 12 indexed citations

12.

Sp, Nipin, Pramod Darvin, Youn Hee Joung, et al.. (2015). The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts. BMC Cancer. 15(1). 474–474. 37 indexed citations

13.

Darvin, Pramod, Youn Hee Joung, Nipin Sp, et al.. (2015). Tannic acid inhibits the Jak2/STAT3 pathway and induces G1/S arrest and mitochondrial apoptosis in YD-38 gingival cancer cells. International Journal of Oncology. 47(3). 1111–1120. 53 indexed citations

14.

Kang, Dong Young, Pramod Darvin, Youn Hee Joung, et al.. (2015). Induction ofin vitroketosis condition and suppression using methylsulfonylmethane by altering ANGPTL3 expression through STAT5b signaling mechanism. Animal Cells and Systems. 19(1). 30–38. 10 indexed citations

15.

Kang, Dong Young, Pramod Darvin, Youn Hee Joung, et al.. (2015). Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells. International Journal of Oncology. 48(2). 836–842. 15 indexed citations

16.

Joung, Youn Hee, Young Bum Yoo, Pramod Darvin, et al.. (2014). Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathway. International Journal of Oncology. 44(3). 883–895. 38 indexed citations

17.

Darvin, Pramod, Youn Hee Joung, & Young Mok Yang. (2013). JAK2-STAT5B pathway and osteoblast differentiation. PubMed. 2(4). e24931–e24931. 33 indexed citations

18.

Joung, Youn Hee, Pramod Darvin, Ju Woong Jang, et al.. (2013). Hwanggeumchal sorghum extract enhances BMP7 and GH signaling through the activation of Jak2/STAT5B in MC3T3-E1 osteoblastic cells. Molecular Medicine Reports. 8(3). 891–896. 10 indexed citations

19.

Park, Jin‐Hee, Pramod Darvin, Youn Hee Joung, et al.. (2012). Hwanggeumchal sorghum Induces Cell Cycle Arrest, and Suppresses Tumor Growth and Metastasis through Jak2/STAT Pathways in Breast Cancer Xenografts. PLoS ONE. 7(7). e40531–e40531. 68 indexed citations

20.

Hong, Dae Young, Jin Hee Park, Youn Hee Joung, et al.. (2012). Methylsulfonylmethane Suppresses Breast Cancer Growth by Down-Regulating STAT3 and STAT5b Pathways. PLoS ONE. 7(4). e33361–e33361. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact